Pharmacological interactions of vasoconstrictors

Medicina Oral, Patologia Oral y Cirugia Bucal

Volumn 14, Issue 1, 2009, Pages

  Gómez Moreno, Gerardo ^a,b   Guardia, Javier ^a,b   Cutando, Antonio ^b   Calvo Guirado, José Luis ^c  

^a Systemic Pathology ^*  (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

^c UNIVERSITY OF MURCIA   (Spain)

Author keywords

Beta blockers; Cocaine; Epinephrine; General anaesthetics; Odontology; Tricyclic antidepressors

Indexed keywords

ADRENALIN; AMITRIPTYLINE; ANALGESIC AGENT; ANESTHETIC AGENT; BARBITURIC ACID DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBIDOPA PLUS LEVODOPA; COCAINE; DESIPRAMINE; DIGOXIN; DOXEPIN; ENTACAPONE; GLUCOSIDE; GUANADREL; GUANETHIDINE; HALOTHANE; IMIPRAMINE; ISOPRENALINE; LIDOCAINE; LOCAL ANESTHETIC AGENT; METOPROLOL; MONOAMINE OXIDASE INHIBITOR; NORADRENALIN; NORTRIPTYLINE; PROPRANOLOL; THIOPENTAL; THYROID HORMONE; TOLCAPONE; TRICYCLIC ANTIDEPRESSANT AGENT; VASOCONSTRICTOR AGENT;

ADRENERGIC SYSTEM; ANESTHESIA; ANGINA PECTORIS; BLEEDING; DEMOGRAPHY; DEPRESSION; DRUG USE; DRUG WITHDRAWAL; HEALTH; HEART ARREST; HEART ARRHYTHMIA; HEART DISEASE; HEPATITIS; HISTORY; HUMAN; HYPERTENSION; LIFE EXPECTANCY; MELANCHOLIA; NEUROLEPTIC MALIGNANT SYNDROME; NONHUMAN; ODONTOLOGY; PAIN; PARKINSON DISEASE; PHYSICIAN; POPULATION; PRESCRIPTION; REVIEW; RISK;

ADRENERGIC BETA-ANTAGONISTS; ANESTHETICS, GENERAL; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DENTISTRY; DRUG INTERACTIONS; EPINEPHRINE; HUMANS; VASOCONSTRICTOR AGENTS;

EID: 59949094177     PISSN: 16984447     EISSN: 16986946     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Stockley IH. Stockley's Drug Interactions, 6th ed. London: Pharmaceutical Press; 2002.
2. Hersh EV, Moore PA. Adverse drug interactions in dentistry. Periodontol 2000. 2008;46:109-42.
3. Gómez Moreno G, Cutando A, Arana C. Visión Odontologica de las Inte-racciones Farmacológicas. Granada: Grupo Editorial Universitario; 2006.
4. FASS (Pharmaceutical Specialities in Sweden). [homepage on the Internet]. Stockholm: INFO Lakemedelsinformation AB (Drug information); 1997. [Cited 2004 Mar 25]. Avaliable from: http://www.fass.se (Swedish).
5. Moore PA, Gage TW, Hersh EV, Yagiela JA, Haas DA. Adverse drug interactions in dental practice. Professional and educational implications. J Am Dent Assoc. 1999 Jan;130(1):47-54.
6. Silvestre FJ, Verdú MJ, Sanchís JM, Grau D, Peñarrocha M. Effects of vasoconstrictors in dentistry upon systolic and diastolic arterial pressure. Med Oral. 2001 Jan-Feb;6(1):57-63.
7. Pipa-Vallejo A, García-Pola-Vallejo MJ. Local anesthetics in dentistry. Med Oral Patol Oral Cir Bucal. 2004 Nov-Dec;9(5):440-3; 438-40.
8. Naftalin LW, Yagiela JA. Vasoconstrictors: indications and precautions. Dent Clin North Am. 2002 Oct;46(4):733-46.
9. Niwa H, Sugimura M, Satoh Y, Tanimoto A. Cardiovascular response to epinephrine-containing local anesthesia in patients with cardiovascular disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 Dec;92(6):610-6.
10. Hersh EV, Giannakopoulos H, Levin LM, Secreto S, Moore PA, Peterson C, et al. The pharmacokinetics and cardiovascular effects of high-dose articaine with 1:100,000 and 1:200,000 epinephrine. J Am Dent Assoc. 2006 Nov;137(11):1562-71.
11. Fangmann P, Assion HJ, Juckel G, González CA, López- Muñoz F. Half a century of antidepressant drugs: on the clinical introduction of monoamine oxidase inhibitors, tricyclics, and tetracyclics. Part II: tricyclics and tetracyclics. J Clin Psychopharmacol. 2008 Feb;28(1):1-4.
12. Glassman AH, Pardell R, Woodring S. Cardiovascular effects of the standard tricyclic antidepressants. Clin Chem. 1988 May;34(5):856-8.
13. Yagiela JA. Adverse drug interactions in dental practice: interactions associated with vasoconstrictors. Part V of a series. J Am Dent Assoc. 1999 May;130(5):701-9.
14. Weinberg MA, Fine JB. The importance of drug interactions in dental practice. Dent Today. 2001 Sep;20(9):88-93.
15. Boakes AJ, Laurence DR, Teoh PC, Barar FS, Benedikter LT, Prichard BN. Interactions between sympathomimetic amines and antidepressant agents in man. Br Med J. 1973 Feb 10;1(5849):311-5.
16. Sims PJ, Sims KM. Drug interactions important for periodontal therapy. Periodontol 2000. 2007;44:15-28.
17. Zhang C, Banting DW, Gelb AW, Hamilton JT. Effect of beta-adrenore-ceptor blockade with nadolol on the duration of local anesthesia. J Am Dent Assoc. 1999 Dec;130(12):1773-80.
18. Gibson RM, Meechan JG. The effects of antihypertensive medication on dental treatment. Dent Update. 2007 Mar;34(2):70-2, 75-6, 78.
19. Gandy W. Severe epinephrine-propranolol interaction. Ann Emerg Med. 1989 Jan;18(1):98-9.
20. Hilley MD, Milam SB, Giescke AH Jr, Giovannitti JA. Fatality associated with the combined use of halothane and gingival retraction cord. Anesthe-siology. 1984 Jun;60(6):587-8.
21. Brand HS, Gonggrijp S, Blanksma CJ. Cocaine and oral health. Br Dent J. 2008 Apr 12;204(7):365-9.
22. Chiu YC, Brecht K, DasGupta DS, Mhoon E. Myocardial infarction with topical cocaine anesthesia for nasal surgery. Arch Otolaryngol Head Neck Surg. 1986 Sep;112(9):988-90.
23. Goulet JP, Pérusse R, Turcotte JY. Contraindications to vasoconstrictors in dentistry: Part III. Pharmacologic interactions. Oral Surg Oral Med Oral Pathol. 1992 Nov;74(5):692-7.
24. Silva JE, Bianco SD. Thyroid-adrenergic interactions: physiological and clinical implications. Thyroid. 2008 Feb;18(2):157-65.
25. Pérusse R, Goulet JP, Turcotte JY. Contraindications to vasoconstrictors in dentistry: Part II. Hyperthyroidism, diabetes, sulfite sensitivity, cortico-dependent asthma, and pheochromocytoma. Oral Surg Oral Med Oral Pathol. 1992 Nov;74(5):687-91.
26. Yagiela JA, Duffin SR, Hunt LM. Drug interactions and vasoconstrictors used in local anesthetic solutions. Oral Surg Oral Med Oral Pathol. 1985 Jun;59(6):565-71.
27. Rosenberg M, Yagiela J. Drug interactions: COMT inhibitors. J Mass Dent Soc. 2001 Summer;50(2):44-6.
28. The Entacapone to Tolcapone Switch Study Investigators. Entacapone to tolcapone switch: Multicenter double-blind, randomized, active-controlled trial in advanced Parkinson's disease. Mov Disord. 2007 Jan;22(1):14-9.
29. Hollman A. Drugs for atrial fibrillation. Digoxin comes from Digitalis lanata. BMJ. 1996 Apr 6;312(7035):912.
30. Becker DE. Cardiovascular drugs: implications for dental practice part 1 - cardiotonics, diuretics, and vasodilators. Anesth Prog. 2007 Winter;54(4):178-85.